LCAR-B38M

J&J hustles Legend’s promising BCMA CAR-T into PhI/II trial, winning an FDA green light to begin recruiting patients
Endpoints
Wed, 05/30/18 - 08:34 pm
Legend Biotech
CAR-T
LCAR-B38M
Multiple Myeloma
J&J wows with a $350M cash deal to partner on CAR-T with Legend, a one-time unknown until its star turn at ASCO
Endpoints
Thu, 12/21/17 - 10:38 pm
JNJ
CAR-T
Legend Biotech
LCAR-B38M
BCMA
China
ASCO dark horse Nanjing Legend Biotech shines with promising CAR-T data
Fierce Biotech
Tue, 06/6/17 - 10:41 am
ASCO 2017
Nanjing Legend Biotech
CAR-T
LCAR-B38M